我国空中医疗急救发展现状与体系构建建议

目的 探讨我国空中医疗急救发展现状及体系构建策略。方法 基于现有资料分析我国空中医疗急救发展现状、模式、问题与挑战。结果 近年来我国通航企业及飞行器数量发展迅速,但是存在总体不足、多数通航企业规模较小等问题。空中急救网络主要有航空公司主导、医院或急救中心主导、通航企业-医院联合和政府主导4种发展模式;各模式均为自由发展,距离国家规划的目标尚远;现有体系内要素分散、结构不完整,大范围的空中急救网络尚未形成。结论 我国地形复杂,建成覆盖面广、运行模式统一的空中医疗急救网络困难较大,建议全国范围内构建多个主体共同参与的多元化区域性空中急救体系,而在青藏高原及周边区域优先构建公益性空中医疗急救体系。     

核电站事故的公众防护行动

随着核能发展不断推进,居住在核电站周围的公众数量越来越多,但是他们普遍缺乏对核辐射的基础知识,对核事故的防护行动也知之甚少。而及时、正确的防护行动可以将核电站事故对公众的健康危害降到最低。本文介绍了核电站事故后,公众的防护行动：隐蔽、体表污染去污、撤离、服用稳定性碘、食品和饮用水控制、个人防护措施、宠物照料、心理援助等,以指导公众在事故后开展正确的自救与互救,提高公众对核电站事故的应急响应能力。     

观察脊柱脊髓损伤不同时间段手术的术后神经功能恢复情况

目的对脊髓损伤患者不同时间段尽早急诊手术的术后神经功能康复情况进行观察。方法选取35例脊柱脊髓损伤并进行创伤外科急诊手术治疗患者的临床资料,进行统计并分析比较其不同时间段进行手术,术后的神经功能康复情况。结果 35例患者术后神经功能恢复均较术前明显好转,8小时手术的患者神经功能康复较8小时的患者好,越早进行手术的患者神经功能康复越好,所有患者术后的脊髓功能ASIA评分(针刺觉评分、轻触觉评分、运动评分)均较术前提高,且时间越早手术的术后ASIA评分提高值就越高,与术前、不同时间段之间比较P0.05,差异具有统计学意义。结论对于脊髓损伤的患者需加快其院外及院内的抢救,以最大限度降低患者的损伤,提高其术后神经功能康复力。     

华佗再造丸抗血栓作用及对实验性微循环障碍的影响

目的 观察华佗再造丸对血瘀证动物模型体内血栓,体外血栓的作用及对实验性微循环障碍的影响。方法 实验体国栓采用Ｃｈａｎｄｅｌ法,体内血栓采用动物颈动脉电流刺激法,高分子右旋糖酐造成动物循环障碍。结果 华佗再造丸具有抑制体外全形成、延长体内血栓作用并能降低动物的血液粘度、抑制血小板聚集性,改善动物脑供血供和软脑膜微循环障碍的功能。结论 华佗再造丸具有活血化瘀、拮抗血栓形成的功效,是治疗脑血栓后遗症的     

旅游区院前急救模式探讨

目的：探讨旅游区院前急救模式。方法：对２６６例院急救病例进行分类处理。结果：占前三位疾病是外伤、中毒、心脑血管疾病,除８例死亡外,全部转送院内诊治。结论：院前急救是急诊医学的关键环节,关系到院内进一步急救的抢救成功率。     

The symptom of headache in Emergency Departments. The experience of a neurology emergency department

Although the symptom of headache is a frequent cause of Emergency Department examinations, it is often considered to be of little clinical relevance in comparison with other emergencies and is usually treated only symptomatically. But how frequently does a simple headache mask a severe cerebral pathology? To answer this question, we studied a consecutive series of patients examined at the Neurology Emergency Department of Turin's Ospedale Molinette over a period of three months; the patients were then followed-up for more than two years in order to confirm the diagnoses.Of 215 cases of acute headache, 121 (56%) were essential and 94 (44%) symptomatic; of the latter, 18 (8.3%) were the only clinical manifestation of a severe cerebral pathology (10 hemorrhages, 2 ischemias, 6 tumours). In diagnosing these 18 cases, 72 EEG, 57 CT and 4 rachicentesis examinations were carried out and their diagnostic efficacy is here analysed. Our data show the importance of a careful evaluation of the symptom of headache in Emergency Departments and the need to send any doubtful cases to a facility specialised in coping with such emergencies.

---

Sommario Il sintomo cefalea costituisce un frequente motivo di visita in Pronto Soccorso, spesso considerato di scarsa rilevanza clinica rispetto ad altre urgenze e per lo più trattato solo dal punto di vista sintomatico. Ma in quanti di questi casi una semplice cefalea nasconde una grave patologia cerebrale? A questo proposito abbiamo effettuato uno studio presso il Dipartimento di Emergenza di Neurologia dell'Ospedale Molinette di Torino su una serie consecutiva di pazienti che sono stati visitati per cefalea nell'arco di tre mesi, seguendoli quindi nel tempo con un follow-up di oltre due anni per la verifica diagnostica.Su 215 cefalee acute, le cefalee essenziali sono risultate 121 (56%), e quelle sintomatiche 94 (44%). Tra queste ultime, 18 (8,3%) erano l'unica manifestazione clinica di una grave patologia cerebrale (10 emorragie, 2 ischemie, 6 tumori). Per diagnosticare questi 18 casi sono stati eseguiti 72 EEG, 57 T.C e 4 rachicentesi; di questi esami viene quindi analizzata l'efficacia ai fini diagnostici. Da questi dati emerge quindi l'importanza di un'attenta valutazione del sintomo cefalea in Pronto Soccorso e la necessità di inviare, nei casi dubbi, il paziente in una struttura specializzata per queste emergenze.

     

Failure rates among perfect users and during perfect use: a distinction that matters

To make an informed decision when choosing a contraceptive, women and couples need to know how effective different methods are when used perfectly, where perfect use is defined as following the directions for use. In this article, we show that unbiased estimates of pregnancy rates during perfect use can be guaranteed only if information on consistency and correctness of use is available for each menstrual cycle. The estimated probability of pregnancy during a year of perfect use among the subset of women who always used a method perfectly will be biased upward.     

The public health implications of the 1995 'pill scare'

The warning issued by the UK Committee on Safety Medicines in October 1995, followed by their 'Dear Doctor' letter of October 18, 1995, that oral contraceptive pills containing gestodene or desogestrel were associated with a higher risk of venous thromboembolism has had a negative impact on public heath. A significant number of women either switched brands or ceased contraception altogether following the announcement. National data suggest a strong association between the pill scare and a substantial increase in the number of unintended pregnancies, particularly significant among younger women, with use of oral contraception falling from 40 to 27% of under 16s between 1995-1996 and 1996-1997. The resulting cost of the increase in births and abortions to the National Health Service has been estimated at about Pound Sterling 21 million for maternity care and from Pound Sterling 46 million for abortion provision. The level of risk should, in future, be more carefully assessed and advice more carefully presented in the interests of public health.     

Safety of modern oral contraception: the options for women: lessons to be learned

The relatively short history of hormonal contraception has been marked by a series of 'pill scares', all of which--after creating panic among users--were proven to be unfounded in terms of public health impact. The latest pill scare, provoked by regulatory action in the United Kingdom and the Federal Republic of Germany in response to the publication of a series of articles indicating a doubling of risk of deep venous thrombosis in users of oral contraceptives containing third-generation progestins, seems finally settled: both the British and the German Drug Regulatory Authorities have now reverted their verdict. The damage unfortunately stays: hundreds of thousands of women have been compelled to abandon the pill of their choice, often deciding to drop contraception altogether, thereby exposing themselves to unwanted pregnancy and--in a number of cases--to pregnancy termination. This latest episode should be turned into something positive: we need to learn that, in the case of drugs in widespread use, before restrictive action is taken--and except for very rare and specific instances--the scientific community must carry out an exhaustive debate on the reality and importance of the observed effects. Although the public should, in each instance, be properly informed, it is only after this process has been completed that restrictive action should be taken. It is hoped that, after this last episode, all concerned have learned this simple principle and will accept being guided by it from now on.     

The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium

Contraceptive use often leads to disrupted endometrial bleeding patterns in women. In this study, two different contraceptive regimes (Mircette, a monophasic oral contraceptive and Implanon, a long-acting gestagen) were used and their effects on the immunoreactivity of vascular endothelial growth factor (VEGF), oestrogen receptor (ER), progesterone receptor (PR) and endothelial cell number were determined. During the untreated normal cycle, there was a significant increase (P = 0.005) in glandular VEGF immunoreactivity and a significant decrease (P < 0.05) in PR immunoreactivity in the mid- and late secretory phases compared with the proliferative phase. There was a significant positive correlation (gamma = 0.38, P = 0.046) between stromal VEGF immunoreactivity and endothelial cell number. This correlation was also apparent during treatment with Implanon, but not with Mircette. Disrupted bleeding patterns were associated with Implanon and, to a lesser extent, with Mircette. Both contraceptives significantly reduced glandular VEGF immunoreactivity. Implanon significantly increased (P = 0.016) glandular PR staining, but Mircette significantly reduced (P = 0.027) stromal PR staining when compared with secretory before-treatment biopsies. There were no changes in endothelial cell number or glandular or stromal ER during the normal cycle, or with use of either contraceptive. There was no association between the parameters measured with bleeding patterns and histological category.